Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Ixazomib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ixazomib 2.3mg capsules
0801050CCAAAAAA
|
Ixazomib | Ixazomib | Malignant Disease and Immunosuppression | No data available |
|
Ixazomib 3mg capsules
0801050CCAAABAB
|
Ixazomib | Ixazomib | Malignant Disease and Immunosuppression | No data available |
|
Ixazomib 4mg capsules
0801050CCAAACAC
|
Ixazomib | Ixazomib | Malignant Disease and Immunosuppression | No data available |
|
Ninlaro 2.3mg capsules
0801050CCBBAAAA
|
Ninlaro | Ixazomib | Malignant Disease and Immunosuppression | No data available |
|
Ninlaro 3mg capsules
0801050CCBBABAB
|
Ninlaro | Ixazomib | Malignant Disease and Immunosuppression | No data available |
|
Ninlaro 4mg capsules
0801050CCBBACAC
|
Ninlaro | Ixazomib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.